Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data
Journal of the American Geriatrics Society · 2026
DOI: 10.1111/jgs.70217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2026. Verfasst von Ryan Weaver und 3 weiteren Autor:innen. Beteiligte Einrichtung: VCU School of Pharmacy, Department of Pharmacotherapy & Outcomes Science, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Primary Health Care, Medical Marijuana, Geriatrics, Ambulatory Care Facilities. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Cannabis use is rising among adults, yet few users receive structured medical supervision. Older users face unique risks necessitating specialized oversight. Given their longitudinal relationships and detailed understanding of patients' health and goals, primary care providers are well‐positioned to guide decisions and education about medical cannabis (MC). Further, because of their expertise in managing complex considerations of aging, geriatricians in particular are uniquely qualified to offer safe, evidence‐informed guidance to older adults using MC. This led us to develop and implement a physician‐led MC clinic embedded in a geriatric primary care practice.
Methods
A monthly, physician‐led MC certification clinic was established to provide individualized evaluation, safety assessment, medication review, and counseling, with support from pharmacy and nursing. The clinic was shaped by the legal, regulatory, and clinical context. The demographic characteristics, medical and qualifying conditions, and medication profiles of patients with a MC clinic visit between Jan 1, 2022, and July 1, 2024, were evaluated retrospectively. Data was analyzed descriptively.
Results
In 30 months, 144 visits were completed. The population had a mean age of 65 years (SD 13.8), was 59.7% female, and diverse. There was high clinical complexity (mean 20.9 comorbid conditions, 14.7 medications). Pain was the predominant qualifying condition (88.9%), with anxiety (13.9%) and insomnia (11.8%) also common. Drug utilization reviews revealed a mean of 4.6 interactions per patient. Common medications included CNS depressants (66.0%), pain medications (59.0%), and psychiatric medications (56.9%).
Conclusions
This model demonstrates a feasible approach to integrating MC care into primary care for medically complex older adults. This integration prevents MC care fragmentation, provides thorough drug interaction screening, and supports informed MC risk–benefit assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VCU School of Pharmacy, Department of Pharmacotherapy & Outcomes Science, Richmond, Virginia, USA.
- VCU School of Medicine, Department of Internal Medicine, Division of Geriatric Medicine, Richmond, Virginia, USA.
ORCID-Profile: Kristin M Zimmerman
Zitieren
APA
Weaver, R., Velez, B., Weissberger, M. L., & Zimmerman, K. M. (2026). Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.70217
Vancouver
Weaver R, Velez B, Weissberger ML, Zimmerman KM. Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data. Journal of the American Geriatrics Society. 2026. doi:10.1111/jgs.70217
BibTeX
@article{Weaver2026,
author = {Weaver, Ryan and Velez, Brian and Weissberger, Michael L and Zimmerman, Kristin M},
title = {Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data},
journal = {Journal of the American Geriatrics Society},
year = {2026},
doi = {10.1111/jgs.70217}
}
EUVIMED